Top performers last week: $WBD up 18.28%, $MSTR up 16.74%, $DHI up 12.91%, $COIN up 12.39%, $OQL up 7.89%, $UNH up 7.84%, $STT ...

Jefferies analyst Glen Santangelo reinstates Viatris (NASDAQ:VTRS) with a Buy and announces $15 price target.

The clinical trial is a bridging study requiring a limited number of Japanese patients to participate in a study similar in des...

Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Pri...

The Civil Division of the DOJ has also informed the Company that it does not expect to take any further actions in connection w...

Viatris reports Q1 EPS in line with consensus at $0.67, with sales slightly missing expectations at $3.66 billion. Strong growt...

Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising u...